BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21163253)

  • 21. DNA methyltransferase 1 is essential for initiation of the colon cancers.
    Morita R; Hirohashi Y; Suzuki H; Takahashi A; Tamura Y; Kanaseki T; Asanuma H; Inoda S; Kondo T; Hashino S; Hasegawa T; Tokino T; Toyota M; Asaka M; Torigoe T; Sato N
    Exp Mol Pathol; 2013 Apr; 94(2):322-9. PubMed ID: 23064049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Radiotherapy with
    Huang T; Lee JS; Klibanov AL; He J
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer stem cell-like cells exist in mucoepidermoid carcinoma cell line MC3.
    Zhang L; Xia Y; Li L; Wang Y; Liu Y; Li C; Yu T
    Oncol Res; 2012; 20(12):589-600. PubMed ID: 24139417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibody therapy for malignant mesothelioma: humanized anti-cD26 mAb therapy].
    Morimoto C; Ohnuma K
    Nihon Rinsho; 2012 Dec; 70(12):2177-82. PubMed ID: 23259393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of CD71 transferrin receptor characterizes human gastric adenosquamous carcinoma stem cells.
    Ohkuma M; Haraguchi N; Ishii H; Mimori K; Tanaka F; Kim HM; Shimomura M; Hirose H; Yanaga K; Mori M
    Ann Surg Oncol; 2012 Apr; 19(4):1357-64. PubMed ID: 21523522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A role for the JARID1B stem cell marker for continuous melanoma growth.
    Held M; Bosenberg M
    Pigment Cell Melanoma Res; 2010 Aug; 23(4):481-3. PubMed ID: 20546534
    [No Abstract]   [Full Text] [Related]  

  • 27. Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma.
    Wu L; Blum W; Zhu CQ; Yun Z; Pecze L; Kohno M; Chan ML; Zhao Y; Felley-Bosco E; Schwaller B; de Perrot M
    BMC Cancer; 2018 Apr; 18(1):471. PubMed ID: 29699510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Development of New Therapy for Malignant Mesothelioma Based on CD26 Molecule].
    Morimoto C; Ohnuma K
    Gan To Kagaku Ryoho; 2016 Jul; 43(7):855-62. PubMed ID: 27431629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multipotent cancer stem cells derived from human malignant peritoneal mesothelioma promote tumorigenesis.
    Varghese S; Whipple R; Martin SS; Alexander HR
    PLoS One; 2012; 7(12):e52825. PubMed ID: 23285196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amplification of tumor inducing putative cancer stem cells (CSCs) by vitamin A/retinol from mammary tumors.
    Sharma RB; Wang Q; Khillan JS
    Biochem Biophys Res Commun; 2013 Jul; 436(4):625-31. PubMed ID: 23764401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents.
    Pasdar EA; Smits M; Stapelberg M; Bajzikova M; Stantic M; Goodwin J; Yan B; Stursa J; Kovarova J; Sachaphibulkij K; Bezawork-Geleta A; Sobol M; Filimonenko A; Tomasetti M; Zobalova R; Hozak P; Dong LF; Neuzil J
    PLoS One; 2015; 10(5):e0119549. PubMed ID: 25932953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomics of cancer stem cells.
    Skvortsov S; Debbage P; Skvortsova I
    Int J Radiat Biol; 2014 Aug; 90(8):653-8. PubMed ID: 24350919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear localization of CD26 induced by a humanized monoclonal antibody inhibits tumor cell growth by modulating of POLR2A transcription.
    Yamada K; Hayashi M; Madokoro H; Nishida H; Du W; Ohnuma K; Sakamoto M; Morimoto C; Yamada T
    PLoS One; 2013; 8(4):e62304. PubMed ID: 23638030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of CD26+ Cancer Stem Cells with Metastatic Properties in Colorectal Carcinogenesis.
    Cheung AH; Iyer DN; Lam CS; Ng L; Wong SKM; Lee HS; Wan T; Man J; Chow AKM; Poon RT; Pang R; Law WL
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28545226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A preliminary study on the origin of human lung adenocarcinoma stem cells from lung bonchioalveolar stem cells.].
    Zheng B; Zhou J; Geng Q; Dong Q
    Zhongguo Fei Ai Za Zhi; 2008 Dec; 11(6):759-64. PubMed ID: 20797324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The application of cancer stem cell model in malignant mesothelioma.
    Bronte G; Procopio AD; Graciotti L
    Crit Rev Oncol Hematol; 2022 Jun; 174():103698. PubMed ID: 35525390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introduction to the molecular biology of cancer: translation to the clinic.
    Ruddon RW
    Prog Mol Biol Transl Sci; 2010; 95():1-8. PubMed ID: 21075326
    [No Abstract]   [Full Text] [Related]  

  • 38. Expression of Concern: Identification of CD24 as a Cancer Stem Cell Marker in Human Nasopharyngeal Carcinoma.
    PLOS ONE Editors
    PLoS One; 2019; 14(1):e0210304. PubMed ID: 30605487
    [No Abstract]   [Full Text] [Related]  

  • 39. Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity.
    Cortes-Dericks L; Froment L; Boesch R; Schmid RA; Karoubi G
    BMC Cancer; 2014 Apr; 14():304. PubMed ID: 24884875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical Repurposing of Sitagliptin as a Drug Candidate for Colorectal Cancer by Targeting
    Shih JW; Wu ATH; Mokgautsi N; Wei PL; Huang YJ
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.